| Metric | Q4 2025 | Q3 2025 | Q4 2024 | QoQ Change | YoY Change |
|---|---|---|---|---|---|
| Revenue | $5.5B | — | — | — | — |
| Op. Income | $853M | — | — | — | — |
| Gross Margin | 41.5% | — | — | — | — |
| Net Margin | 6.7% | — | — | — | — |
| EPS (Diluted) | $4.22 | — | — | — | — |
| Free Cash Flow | $367M | — | — | — | — |
| Item | Amount |
|---|---|
| REVENUE | $5.5B |
| Cost of Revenue | $3.2B |
| GROSS PROFIT | $2.3B |
| R&D Expenses | $0 |
| Selling & Marketing | $0 |
| General & Administrative | $0 |
| SG&A Expenses | $0 |
| Other Expenses | $1.4B |
| Operating Expenses | $1.4B |
| Cost & Expenses | $4.7B |
| OPERATING INCOME | $853M |
| Interest Income | $0 |
| Interest Expense | $0 |
| Other Income/Expenses | -$172M |
| INCOME BEFORE TAX | $681M |
| Income Tax Expense | $37M |
| Net Income from Continuing Ops | $644M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $371M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $371M |
| D&A | $231M |
| EBIT | $869M |
| EBITDA | $1.1B |
| EPS | $4 |
| EPS Diluted | $4 |
| Item | Amount |
|---|---|
| REVENUE | $5.5B |
| Cost of Revenue | $3.2B |
| GROSS PROFIT | $2.3B |
| R&D Expenses | $0 |
| Selling & Marketing | $0 |
| General & Administrative | $0 |
| SG&A Expenses | $0 |
| Other Expenses | $1.4B |
| Operating Expenses | $1.4B |
| Cost & Expenses | $4.7B |
| OPERATING INCOME | $853M |
| Interest Income | $0 |
| Interest Expense | $0 |
| Other Income/Expenses | -$172M |
| INCOME BEFORE TAX | $681M |
| Income Tax Expense | $37M |
| Net Income from Continuing Ops | $644M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $371M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $371M |
| D&A | $231M |
| EBIT | $869M |
| EBITDA | $1.1B |
| EPS | $4 |
| EPS Diluted | $4 |
| Item | Amount |
|---|---|
| Net Income | $371M |
| Depreciation & Amortization | $236M |
| Stock-Based Compensation | $25M |
| Deferred Income Tax | $0 |
| Other Non-Cash Items | $203M |
| Change in Working Capital | -$104M |
| OPERATING CASH FLOW | $731M |
| Capital Expenditure | -$364M |
| Acquisitions (Net) | -$42M |
| Purchases of Investments | $0 |
| Sales/Maturities of Investments | $0 |
| Other Investing Activities | $17M |
| NET CASH FROM INVESTING | -$389M |
| Net Debt Issuance | -$27M |
| Common Stock Repurchased | -$202M |
| Common Dividends Paid | $0 |
| Other Financing Activities | -$205M |
| NET CASH FROM FINANCING | -$434M |
| FREE CASH FLOW | $367M |
| Net Change in Cash | -$92M |
| Item | Amount |
|---|---|
| Cash & Equivalents | $2.9B |
| Short-Term Investments | $0 |
| Net Receivables | $2.6B |
| Inventory | $348M |
| Other Current Assets | $2.1B |
| TOTAL CURRENT ASSETS | $7.8B |
| PP&E (Net) | $6.3B |
| Goodwill | $11.2B |
| Intangible Assets | $1.3B |
| Long-Term Investments | $2.9B |
| Tax Assets | $0 |
| Other Non-Current Assets | $84M |
| TOTAL NON-CURRENT ASSETS | $21.8B |
| TOTAL ASSETS | $29.7B |
| Account Payables | $1.4B |
| Short-Term Debt | $79M |
| Deferred Revenue | $0 |
| Other Current Liabilities | $1.8B |
| TOTAL CURRENT LIABILITIES | $4.5B |
| Long-Term Debt | $13.1B |
| Deferred Revenue NC | $0 |
| Deferred Tax Liabilities | $0 |
| Other Non-Current Liabilities | $3.1B |
| TOTAL NON-CURRENT LIABILITIES | $16.2B |
| TOTAL LIABILITIES | $20.7B |
| Common Stock | $8M |
| Additional Paid-In Capital | $4.9B |
| Retained Earnings | $4.4B |
| Treasury Stock | -$4.9B |
| Accum. Other Comp. Income | -$181M |
| Other Equity | $0 |
| TOTAL STOCKHOLDERS' EQUITY | $4.2B |
| Minority Interest | $4.8B |
| TOTAL EQUITY | $9.0B |
| TOTAL LIABILITIES & EQUITY | $29.7B |
| Total Debt | $13.2B |
| Net Debt | $10.3B |
